Replies to post #32403 on Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Just a silly question as we wait for results. If in 2023 we get very postive results for the adjuvant group for AML ........... if a phase one study for Psoriasis is somehow worth 3 Billion ....... what should MRKR jump up to on positive AML news?
5 Billion? 10 Billion? 20 Billion?
People will say, oh MRKR can triple or quadruple .... to what, 75 Million or 100 Million?
That is STILL total BS. If phase one Psoriasis trial is worth 3 billion, an AML cure should be at least 10 times that. I know a jump to 30 billion ain't going to happen, but the disjointed, out of touch anti-reality of these market caps are just sickening.